Robert E. Gagnon
Chief Financial Officer at Opus Genetics, Inc. (IRD) since September 2025
Robert E. Gagnon has filed 47 insider reports with the SEC since December 2021, as director at Bone Biologics Corp (BBLG), chief Financial Officer at Opus Genetics, Inc. (IRD) and director at Verastem, Inc. (VSTM) and at 3 more companies. In the last 12 months Robert E. Gagnon sold $193K of stock on the open market. The latest filing, on September 30, 2026, reports grant or award at Bone Biologics Corp (BBLG).
- Filings
- 47
- Companies
- 6
- Bought on market
- None
- Sold on market
- $527K
Companies where Robert E. Gagnon is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince January 2024 | 0 | $0.2685 | Sep 30, 2026 | ||||
| Chief Financial Officersince September 2025 | 556,375 | $191K | $3.99 | Sep 8, 2026 | |||
| Directorsince December 2022 | 41,678 | $336K | $6.33 | Jul 23, 2026 | |||
| Directorsince July 2025 | 27,556 | $8.66 | Jun 11, 2026 | ||||
| Directorsince March 2026 | 3,062,500 | $1.525 | Mar 18, 2026 | ||||
| Director | Jan 12, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 28, 2026BBLGSEC Form 4 filed by Director Gagnon Robert E.Form 4Grant or award
- Sep 3, 2026-$127KIRDChief Financial Officer Gagnon Robert E. sold $127,212 worth of shares (28,000 units at $4.54) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 556,375 units to cover withholding taxForm 4Open-market sale10b5-1 plan
- Jul 23, 2026-$22.9KIRDChief Financial Officer Gagnon Robert E. sold $22,942 worth of shares (7,783 units at $2.95), decreasing direct ownership by 1% to 584,375 units to cover taxesForm 4Open-market sale
- Jul 23, 2026~$188KVSTMRobert E. Gagnon plans to sell 31,924 shares (~$188K)Form 144Planned sale
- Jun 25, 2026~$90.5KVSTMRobert E. Gagnon plans to sell 21,492 shares (~$90.5K)Form 144Planned sale
- Jun 9, 2026HBIODirector Gagnon Robert E. was granted 16,556 shares, increasing direct ownership by 151% to 27,556 unitsForm 4Grant or award
- May 27, 2026~$87.6KVSTMRobert E. Gagnon plans to sell 20,103 shares (~$87.6K)Form 144Planned sale
- Apr 23, 2026-$40.7KIRDChief Financial Officer Gagnon Robert E. sold $40,658 worth of shares (7,842 units at $5.18), decreasing direct ownership by 1% to 592,158 units (withholding obligation)Form 4Open-market sale
- Mar 18, 2026PPBTRobert E. Gagnon became an insiderForm 3New insider
- Jan 22, 2026IRDChief Financial Officer Gagnon Robert E. was granted 400,000 shares, increasing direct ownership by 200% to 600,000 unitsForm 4Grant or award
- Dec 16, 2025-$2,587VSTMDirector Gagnon Robert E. sold $2,587 worth of shares (283 units at $9.14), decreasing direct ownership by 0.67% to 41,678 unitsForm 4Open-market sale
- Sep 16, 2025-$2,807VSTMDirector Gagnon Robert E. sold $2,807 worth of shares (281 units at $9.99), decreasing direct ownership by 0.67% to 41,961 unitsForm 4Open-market sale
- Sep 10, 2025IRDChief Financial Officer Gagnon Robert E. was granted 200,000 sharesForm 4Grant or award
- Sep 2, 2025IRDRobert E. Gagnon became an insiderForm 3New insider
- Jul 16, 2025HBIODirector Gagnon Robert E. was granted 110,000 sharesForm 4Grant or award
- Jul 16, 2025HBIORobert E. Gagnon became an insiderForm 3New insider
- Jun 16, 2025-$1,605VSTMDirector Gagnon Robert E. sold $1,605 worth of shares (284 units at $5.65), decreasing direct ownership by 0.67% to 42,242 unitsForm 4Open-market sale
- Jun 4, 2025BBLGSEC Form 4 filed by Director Gagnon Robert E.Form 4Grant or award
- May 22, 2025VSTMDirector Gagnon Robert E. was granted 8,333 shares, increasing direct ownership by 24% to 42,526 unitsForm 4Grant or award
- Mar 17, 2025-$1,974VSTMDirector Gagnon Robert E. sold $1,974 worth of shares (284 units at $6.95), decreasing direct ownership by 0.82% to 34,193 unitsForm 4Open-market sale
- Dec 19, 2024-$1,862VSTMDirector Gagnon Robert E. sold $1,862 worth of shares (415 units at $4.49), decreasing direct ownership by 1% to 34,477 unitsForm 4Open-market sale
- Sep 19, 2024-$365VSTMDirector Gagnon Robert E. sold $365 worth of shares (131 units at $2.79), decreasing direct ownership by 0.37% to 34,892 unitsForm 4Open-market sale
- Sep 17, 2024BBLGSEC Form 4 filed by Director Gagnon Robert E.Form 4Grant or award
- Sep 16, 2024-$804VSTMDirector Gagnon Robert E. sold $804 worth of shares (287 units at $2.80), decreasing direct ownership by 0.81% to 35,023 unitsForm 4Open-market sale
- Jun 20, 2024-$1,408VSTMDirector Gagnon Robert E. was granted 8,333 shares and sold $1,408 worth of shares (414 units at $3.40), increasing direct ownership by 29% to 35,310 unitsForm 4Grant or awardOpen-market sale
- Mar 19, 2024-$4,380VSTMGagnon Robert E. sold $4,380 worth of shares (413 units at $10.61), decreasing direct ownership by 1% to 27,391 unitsForm 4Open-market sale
- Feb 6, 2024-$126KVSTMGagnon Robert E. sold $126,095 worth of shares (9,204 units at $13.70), decreasing direct ownership by 25% to 27,804 unitsForm 4Open-market sale10b5-1 plan
- Feb 6, 2024~$113KVSTMRobert E. Gagnon plans to sell 9,204 shares (~$113K)Form 144Planned sale10b5-1 plan
- Jan 12, 2024-$101KVSTMGagnon Robert E. sold $100,784 worth of shares (9,204 units at $10.95), decreasing direct ownership by 20% to 37,008 unitsForm 4Open-market sale10b5-1 plan
- Jan 12, 2024~$97.9KVSTMRobert E. Gagnon plans to sell 9,204 shares (~$97.9K)Form 144Planned sale10b5-1 plan
- Jan 12, 2024~$97.9KEPIXRobert E. Gagnon plans to sell 9,204 shares (~$97.9K)Form 144Planned sale10b5-1 plan
- Jan 8, 2024BBLGSEC Form 4 filed by Gagnon Robert E.Form 4Grant or award
- Jan 8, 2024BBLGNew insider Gagnon Robert E. claimed no ownership of stock in the companyForm 3New insider
- Dec 19, 2023-$3,175VSTMGagnon Robert E. sold $3,175 worth of shares (414 units at $7.67), decreasing direct ownership by 0.89% to 46,212 unitsForm 4Open-market sale
- Sep 19, 2023-$4,034VSTMSEC Form 4: Gagnon Robert E. sold $4,034 worth of shares (408 units at $9.89), decreasing direct ownership by 0.87% to 46,626 unitsForm 4Open-market sale
- Jun 20, 2023-$4,146VSTMSEC Form 4 filed by Gagnon Robert E.Form 4Open-market sale
- May 15, 2023VSTMSEC Form 4 filed by Gagnon Robert E.Form 4Grant or award
- Dec 19, 2022-$5,492VSTMSEC Form 4: Gagnon Robert E. sold $5,492 worth of shares (13,837 units at $0.40), decreasing direct ownership by 2% to 574,717 unitsForm 4Open-market sale
- Dec 13, 2022VSTMSEC Form 4 filed by Gagnon Robert E.Form 4Grant or award
- Dec 13, 2022VSTMSEC Form 3: New insider Gagnon Robert E. claimed ownership of 588,554 sharesForm 3New insider
- Sep 19, 2022-$1,523VSTMSEC Form 4: Gagnon Robert E. sold $1,523 worth of shares (1,348 units at $1.13), decreasing direct ownership by 0.23% to 588,554 unitsForm 4Open-market sale
- Jun 21, 2022-$1,540VSTMSEC Form 4: Gagnon Robert E. sold $1,540 worth of shares (1,351 units at $1.14), decreasing direct ownership by 0.23% to 589,902 unitsForm 4Open-market sale
- May 16, 2022-$17.1KVSTMSEC Form 4: Gagnon Robert E. was granted 50,000 shares and sold $17,126 worth of shares (16,627 units at $1.03), increasing direct ownership by 6% to 591,253 unitsForm 4Grant or awardOpen-market sale
- Mar 21, 2022-$1,789VSTMSEC Form 4: Gagnon Robert E. sold $1,789 worth of shares (1,409 units at $1.27), decreasing direct ownership by 0.25% to 557,880 unitsForm 4Open-market sale
- Jan 3, 2022-$40.2KVSTMSEC Form 4: Gagnon Robert E. sold $40,205 worth of shares (19,612 units at $2.05), decreasing direct ownership by 3% to 559,289 unitsForm 4Open-market sale
- Dec 20, 2021-$12.5KVSTMSEC Form 4: Gagnon Robert E. sold $12,478 worth of shares (5,497 units at $2.27), decreasing direct ownership by 0.94% to 578,901 unitsForm 4Open-market sale
- Dec 15, 2021VSTMSEC Form 4: Gagnon Robert E. covered exercise/tax liability with 45,329 shares and was granted 148,500 shares, increasing direct ownership by 21% to 584,398 unitsForm 4Grant or awardShares withheld for taxes or exercise price
Compare Robert E. Gagnon with
- Robert E. Gagnon vs Dan Paterson1 shared
- Robert E. Gagnon vs George Magrath1 shared
- Robert E. Gagnon vs Daniel Calkins1 shared
- Robert E. Gagnon vs Siddhesh Rajendra Angle1 shared
- Robert E. Gagnon vs Phillip Terry Meikle II1 shared
- Robert E. Gagnon vs Bruce Stroever1 shared
Other insiders at the same companies
- Dan PatersonVSTM
- George MagrathIRD
- Foundation Fighting Blindness Retinal Degeneration FundIRD
- Daniel CalkinsVSTM
- Siddhesh Rajendra AngleBBLG
- Phillip Terry Meikle IIBBLG
- Bruce StroeverBBLG
- Cam GallagherIRD
- Benjamin R YerxaIRD
- Joseph K SchachleIRD
- Katherine A. EadeHBIO
- William SniderHBIO
- Stephen J DenelskyHBIO
- Seth Benjamin BensonHBIO
- Michael P BaileyVSTM
- Karin Anna TollefsonVSTM
Questions about Robert E. Gagnon
- What is Robert E. Gagnon's role at Opus Genetics, Inc.?
- Robert E. Gagnon reports to the SEC as chief Financial Officer at Opus Genetics, Inc. (IRD), according to the latest filing on September 8, 2026. Robert E. Gagnon has also filed as director at Bone Biologics Corp (BBLG), director at Verastem, Inc. (VSTM), director at Harvard Bioscience Inc (HBIO) and director at Purple Biotech Ltd. (PPBT).
- How many shares does Robert E. Gagnon own?
- After the latest filing that states it, Robert E. Gagnon directly owned 556,375 shares of Opus Genetics, Inc. (IRD), 41,678 shares of Verastem, Inc. (VSTM), 27,556 shares of Harvard Bioscience Inc (HBIO) and 3,062,500 shares of Purple Biotech Ltd. (PPBT). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Robert E. Gagnon bought or sold stock recently?
- The most recent open-market sale was on September 3, 2026: sold 28,000 shares of Opus Genetics, Inc. (IRD) for $127K at an average of $4.54.
- How do I get alerts when Robert E. Gagnon files?
- Follow Robert E. Gagnon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Robert E. Gagnon filed 2 times in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Robert E. Gagnon (SEC CIK 0001504983). Totals count each trade once, skipping amendments whose original is on file, from Dec 17, 2021 on. View on SEC EDGAR · Get this as JSON